Overview

A Study to Evaluate the Drug Levels of Deucravacitinib From Tablets After Oral Administration in Healthy Participants

Status:
Recruiting
Trial end date:
2021-12-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the drug levels of deucravacitinib after oral administration in healthy participants.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
BMS-986165
Famotidine